文献速递关节外科

术前阿片类药物使用与全膝关节和全髋关节置换术后再入院率及翻修率升高相关

Preoperative Opioid Use Is Associated with Higher Readmission and Revision Rates in Total Knee and Total Hip Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

基于2003至2014年两个商业保险及Medicare补充保险数据库,纳入至少连续入组6个月的初次全膝关节置换(TKA)或全髋关节置换(THA)患者,比较术前6个月内不同阿片类药物使用时长与术后30天再入院及早期翻修率的关系。结果显示,术前使用阿片类药物超过60天的患者,其翻修率和30天再入院率均显著高于未使用阿片类药物的患者,调整年龄、性别和Charlson合并症指数后关联持续存在。

要点

  • 术前使用阿片类药物超过60天的TKA患者,1年翻修率2.14%高于未使用者的1.07%(p<0.001)。
  • 术前使用阿片类药物超过60天的THA患者,1年翻修率1.10%高于未使用者的0.38%(p<0.001)。
  • 术前使用阿片类药物超过60天的TKA患者,30天再入院率6.17%高于未使用者的4.82%(p<0.001)。

核心结论

  • 术前阿片类药物使用与TKA和THA术后早期翻修风险显著增加及30天再入院风险显著增加相关。
  • 长期术前使用阿片类药物的TKA和THA患者,不良结局风险和术后医疗资源利用增加。

研究设计与样本

  • 回顾性队列研究,数据来自2003至2014年两个Truven Health MarketScan数据库(商业保险和Medicare加商业补充保险)。
  • 纳入有初次TKA或THA的Current Procedural Terminology(CPT)代码且术前至少连续入组6个月的患者。
  • 通过National Drug Codes(NDCs)识别术前阿片类药物处方,按术前6个月内阿片类药物使用时长分层比较30天再入院率和翻修关节置换率。
  • 1年随访组324,154例患者,3年随访组159,822例患者。

主要发现

  • 未使用阿片类药物的TKA患者翻修率低于术前使用阿片类药物超过60天的患者(1年队列:1.07% vs 2.14%,p<0.001;3年队列:2.58% vs 5.00%,p<0.001)。
  • THA患者呈现相似趋势(1年:0.38% vs 1.10%,p<0.001;3年:1.24% vs 2.99%,p<0.001)。
  • 调整年龄、性别和Charlson合并症指数(CCI)后,上述趋势持续存在。
  • TKA或THA术后30天再入院率,术前未使用阿片类药物的患者显著低于术前使用超过60天的患者(TKA:4.82% vs 6.17%,p<0.001;THA:3.71% vs 5.85%,p<0.001)。
  • 调整年龄、性别和CCI后,30天再入院率的关联持续存在。

局限性

  • 证据等级为预后Level IV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prescription opioid use is epidemic in the U.S. Recently, an association was demonstrated between preoperative opioid use and increased health-care utilization following abdominal surgeries. Given that primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) are 2 of the most common surgical procedures in the U.S., we examined the association of preoperative opioid use with 30-day readmission and early revision rates. METHODS: We reviewed 2003 to 2014 data from 2 Truven Health MarketScan databases (commercial insurance and Medicare plus commercial supplemental insurance). Subjects were included if they had a Current Procedural Terminology (CPT) code for primary TKA or THA and were continuously enrolled in the database for at least 6 months prior to the index procedure. Preoperative opioid prescriptions were identified using National Drug Codes (NDCs). Rates of 30-day readmissions and revision arthroplasty were identified and compared among patients with stratified durations of preoperative opioid use in the 6 months preceding TKA or THA. RESULTS: The study included 324,154 patients in the 1-year follow-up group and 159,822 patients in the 3-year follow-up group. Opioid-naive TKA patients had a lower revision rate than did those with >60 days of preoperative opioid use (1-year cohort: 1.07% compared with 2.14%, p < 0.001; 3-year cohort: 2.58% compared with 5.00%, p < 0.001). A similar trend was noted among THA patients (1-year: 0.38% compared with 1.10%, p < 0.001; 3-year: 1.24% compared with 2.99%, p < 0.001). These trends persisted after adjusting for age, sex, and Charlson Comorbidity Index (CCI). The 30-day readmission rate after TKA or THA was significantly lower for patients with no preoperative opioid use compared with those with >60 days of preoperative opioid use (TKA: 4.82% compared with 6.17%, p < 0.001; THA: 3.71% compared with 5.85%, p < 0.001). Again, this association persisted after adjusting for age, sex, and CCI. CONCLUSIONS: Preoperative opioid use was associated with significantly increased risk of early revision and significantly increased risk of 30-day readmission after TKA and THA. This study illustrates the increased risk of poor outcomes and increased postoperative health-care utilization for patients with long-term opioid use prior to THA and TKA. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Weick J, Bawa H, Dirschl DR, et al. Preoperative Opioid Use Is Associated with Higher Readmission and Revision Rates in Total Knee and Total Hip Arthroplasty. J Bone Joint Surg Am. 2018. PMID: 30020122. doi:10.2106/JBJS.17.01414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。